Monday, July 25, 2005 12:55:18 PM
VJET: GREAT BUY OPPORTUNITY FOR LONG TERM INVESTORS
VJET: Advanced Refractive Technologies ( http://www.advancedrefractive.com ) is a great BUY opportunity for long-term investors looking for continued growth through the coming months. The stock has bottomed-out during the past 3 weeks around .04/.05 on an average volume of 307,500 shares. VJET was trading around .30 three months ago but has since gone down due to lower-than expected sales for their new and improved technology. The following is a quote from the company's recent shareholders meeting explaining how they plan to tackle this problem with increased sales and marketing efforts:
"Initial orders for a relatively new technology require overcoming certain objections, as well as built-in resistance to the technology, the company and the sales force representing the technology. People are resistant to change, thus change happens slowly. To overcome this challenge, the sales and marketing team have established relationships with centers of influence who, in turn, act as product champions and are key to conversion of the early adopters. Sales have been slowly increasing as awareness of benefits and safety improves."
Advanced Refractive Technologies is a medical device company focused on the development and marketing of innovative eye surgery equipment that will result in faster, safer and more effective procedures for two of the largest surgical markets in the world: Corrective Refractive Surgery (LASIK) and Cataract Surgery. Cataract surgery is the most frequently performed surgical procedure worldwide and there is expected to be persistant substantial growth in the LASIK surgical sector.
VJET's new generation of medical devices are designed to make eye surgeries faster, safer and more effective for everyone by utilizing its proprietary waterjet technology. The company's products include Pulsatome, a device that uses pulsed waterjet technology to remove cataracts; and Hydrokeratome, a device that uses a high-pressure micro beam of water to cut a corneal flap during LASIK surgery. They also have exclusive worldwide distribution, sales and marketing rights for EpiLift, a mechanical device used for performing the epithelium separation procedure in Epi-LASIK refractive surgery; and LasiTome, a mechanical device used for creating a corneal flap in traditional LASIK surgical procedures.
This stock definitely deserves some consideration for serious investors looking for an undervalued company with future potential for explosive sales. Keep VJET on your radar for the next few months and consider purchasing some shares while it's cheap, I don't think you will be disappointed.
VJET: Advanced Refractive Technologies ( http://www.advancedrefractive.com ) is a great BUY opportunity for long-term investors looking for continued growth through the coming months. The stock has bottomed-out during the past 3 weeks around .04/.05 on an average volume of 307,500 shares. VJET was trading around .30 three months ago but has since gone down due to lower-than expected sales for their new and improved technology. The following is a quote from the company's recent shareholders meeting explaining how they plan to tackle this problem with increased sales and marketing efforts:
"Initial orders for a relatively new technology require overcoming certain objections, as well as built-in resistance to the technology, the company and the sales force representing the technology. People are resistant to change, thus change happens slowly. To overcome this challenge, the sales and marketing team have established relationships with centers of influence who, in turn, act as product champions and are key to conversion of the early adopters. Sales have been slowly increasing as awareness of benefits and safety improves."
Advanced Refractive Technologies is a medical device company focused on the development and marketing of innovative eye surgery equipment that will result in faster, safer and more effective procedures for two of the largest surgical markets in the world: Corrective Refractive Surgery (LASIK) and Cataract Surgery. Cataract surgery is the most frequently performed surgical procedure worldwide and there is expected to be persistant substantial growth in the LASIK surgical sector.
VJET's new generation of medical devices are designed to make eye surgeries faster, safer and more effective for everyone by utilizing its proprietary waterjet technology. The company's products include Pulsatome, a device that uses pulsed waterjet technology to remove cataracts; and Hydrokeratome, a device that uses a high-pressure micro beam of water to cut a corneal flap during LASIK surgery. They also have exclusive worldwide distribution, sales and marketing rights for EpiLift, a mechanical device used for performing the epithelium separation procedure in Epi-LASIK refractive surgery; and LasiTome, a mechanical device used for creating a corneal flap in traditional LASIK surgical procedures.
This stock definitely deserves some consideration for serious investors looking for an undervalued company with future potential for explosive sales. Keep VJET on your radar for the next few months and consider purchasing some shares while it's cheap, I don't think you will be disappointed.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
